E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry
Open Access
- 15 August 2012
- journal article
- Published by Taylor & Francis in Cell Cycle
- Vol. 11 (16) , 3067-3078
Abstract
Resistance to anti-neoplastic agents is the major cause of therapy failure, leading to disease recurrence and metastasis. E2F1 is a strong inducer of apoptosis in response to DNA damage through its...Keywords
This publication has 41 references indexed in Scilit:
- miRNA-205 Suppresses Melanoma Cell Proliferation and Induces Senescence via Regulation of E2F1 ProteinJournal of Biological Chemistry, 2011
- Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cellsCell Death & Disease, 2010
- GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondriaCell Death & Differentiation, 2010
- ABCA2 transporter deficiency reduces incidence of TRAMP prostate tumor metastasis and cellular chemotactic migrationCancer Letters, 2010
- Role of miRNAs in the progression of malignant melanomaBritish Journal of Cancer, 2009
- microRNA-205 Regulates HER3 in Human Breast CancerCancer Research, 2009
- Suppression of cell growth and invasion by miR-205 in breast cancerCell Research, 2009
- Chromatin structure analyses identify miRNA promotersGenes & Development, 2008
- MicroRNA Gene Expression Deregulation in Human Breast CancerCancer Research, 2005
- Apoptosis and melanoma chemoresistanceOncogene, 2003